Genital reservoir: a barrier to functional cure?

Current Opinion in HIV and AIDS
Pierre Gantner, Jade Ghosn

Abstract

HIV functional cure requires the elimination or a major reduction of HIV reservoir pool including male and female genital HIV reservoirs. A comprehensive understanding of HIV dynamics in these compartments is mandatory. Data from chronically HIV-infected therapy-naïve individuals or fully suppressed on combined antiretroviral therapy (cART) or undergoing ART interruptions are now available. Using paired blood/genital samples, HIV-RNA/DNA quantification and sequencing provide new insights on HIV dynamics in genital reservoirs. In the absence of cART, HIV shedding in semen and cervicovaginal secretions is frequent, resulting most likely from passive transfer of HIV strains that originates from bloodborne virions or infected blood cells. Partial and intermittent HIV compartmentalization in the male and female genital tracts can occur not only in chronically infected ART-naïve individuals but also when cART is used to prevent active blood replication. This transient autonomous HIV replication in the genital reservoir in a few individuals originates from recent transfer of virions or infected blood cells. cART interruption studies showed that blood and genital quasispecies are closely related, in agreement with a passive transfer. A...Continue Reading

References

Feb 25, 1998·The Journal of Urology·J N KriegerR W Coombs
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·T W ChunA S Fauci
Nov 22, 2001·Lancet·A KovacsUNKNOWN WIHS Study Group
Oct 12, 2002·Journal of Medical Virology·Bhudipa ChoudhuryPatricia A Cane
Apr 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·M C StrainJ K Wong
Sep 23, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Maria Pia De PasqualeRichard T D'Aquila
Nov 16, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Astrid K N IversenPeter Skinhøj
Sep 1, 2005·AIDS Research and Human Retroviruses·Giuseppe NunnariRoger J Pomerantz
Jul 14, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Susan Cu-UvinAngela M Caliendo
Jan 2, 2009·Retrovirology·Anna Le TortorecNathalie Dejucq-Rainsford
Aug 28, 2009·AIDS·Prameet M ShethUNKNOWN Toronto Mucosal Immunology Group
Sep 3, 2010·PLoS Pathogens·Jeffrey A AndersonUNKNOWN Center for HIV/AIDS Vaccine Immunology
Sep 20, 2011·The American Journal of Pathology·Claire DeleageNathalie Dejucq-Rainsford
Nov 1, 2011·Pharmacological Reviews·C Yan Cheng, Dolores D Mruk
Feb 5, 2013·Retrovirology·Daniel A Donahue, Mark A Wainberg
Jun 26, 2013·Nature Reviews. Immunology·Bruce D Walker, Xu G Yu
Aug 16, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Benjamin N GreenerAngela D M Kashuba
Dec 12, 2013·AIDS·Alan LandayUNKNOWN Womenʼs Interagency HIV Study
Mar 22, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jade GhosnUNKNOWN Evarist–ANRS EP 49 Study Group
May 3, 2014·Journal of Virology·Sara GianellaUNKNOWN California Collaborative Treatment Group 592 Team
Jan 30, 2015·The Journal of Antimicrobial Chemotherapy·Ivana MassudJ Gerardo García-Lerma
Feb 26, 2015·Immune Network·Sung Ki LeeJee-Hyun Kang
Feb 16, 2016·Trends in Microbiology·Kirston BartonSarah Palmer
Mar 30, 2016·Current Opinion in HIV and AIDS·Guinevere Q Lee, Mathias Lichterfeld
Apr 8, 2016·The Journal of Infectious Diseases·Andrew MujugiraUNKNOWN Partners PrEP Study Team
Jul 20, 2016·The Journal of Antimicrobial Chemotherapy·Pierre GantnerUNKNOWN EVARIST ANRS EP 49 Study Group
Aug 23, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Antoine ChaillonSanjay R Mehta
Oct 30, 2016·The Journal of Infectious Diseases·Arkaitz ImazDaniel Podzamczer
Apr 1, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Meghan D MorrisUNKNOWN International Collaboration of Incident HIV and HCV in Injecting Cohorts (InC3)

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.